Jain PharmaBiotech, June 2012, Pages: 345
CNS.
Various strategies that have been used for manipulating the blood-brain barrier for drug delivery to the brain include osmotic and chemical opening of the blood-brain barrier as well as the use of
Jain PharmaBiotech, June 2012, Pages: 1023
regenerative medicine
Cells therapy and tissue engineering
Therapy based on cells involved in disease
Advantages of therapeutic use of cells
Cell-based drug delivery
Cells as vehicles for gene delivery
Red
Jain PharmaBiotech, June 2012, Pages: 639
cell grafts for stroke
Stimulation of instrinsic stem cells for repair of brain in stroke
Neuroprotective vaccines for stroke
Gene therapy for neuroprotection in cerebrovascular disease
Regulation of
Jain PharmaBiotech, June 2012, Pages: 658
preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of vectors and various techniques are being used to modify the function of genes in vivo without gene
Jain PharmaBiotech, June 2012, Pages: 354
management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines
Jain PharmaBiotech, June 2012, Pages: 755
surgery. Applications of nanobiotechnology are described according to various therapeutic systems. Nanotechnology will markedly improve the implants and tissue engineering approaches as well. Other
Jain PharmaBiotech, June 2012, Pages: 809
patient's own cells are considered to be personalized medicines. Vaccines are prepared from individual patient's tumor cells. Individualized therapeuticstrategies using monoclonal bodies can be directed at
Jain PharmaBiotech, June 2012, Pages: 264
drug-eluting stents.
New cell-based therapeuticstrategies are being developed in response to the shortcomings of available treatments for heart disease. Potential repair by cell grafting or mobilizing
Jain PharmaBiotech, June 2012, Pages: 485
approach for restenosis following angioplasty
miRNA gene therapy for ischemic heart disease
miRNAs as therapeutic targets for cardiovascular diseases
Concluding remarks and future prospects of miRNA in
Woodhead Publishing Ltd, March 2012, Pages: 568
transplantation?
- Future trends
- References
Olfactory mucosa: neural stem and progenitor cells for nervous system repairand cell models of braindisease
A Mackay-Sim, Griffith University, Australia
John Wiley and Sons Ltd, Jan 2011, Pages: 404
involved in the study of the mechanisms of hormonal control of brain damage andrepair, this book gives a comprehensive account of the neuroprotective and neurogenic effects of steroid and polypeptide
Axis Research Mind, July 2010, Pages: 468
strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations
Axis Research Mind, Nov 2011, Pages: 656
CAGR among the regions considered.
On further classification, Population-Based Banks are the fastest growing segment followed by Academics andDisease-Based Banks respectively.
Report Focus:
The
Axis Research Mind, Nov 2011, Pages: 771
classification, Population-Based Banks are the fastest growing segment followed by Academics andDisease-Based Banks respectively.
Report Focus:
The ‘Biorepositories: Applications & Ownership - A Global Market
Axis Research Mind, Nov 2011, Pages: 730
-Pacific and Europe leads in terms of CAGR among the regions considered.
On further classification, Population-Based Banks are the fastest growing segment followed by Academics andDisease-Based Banks
Axis Research Mind, Nov 2011, Pages: 1148
growing segment followed by Academics andDisease-Based Banks respectively. Pharmaceuticals account for the largest share of the entire market, driving a CAGR of 8.5% during the analysis period 2009-2015
Axis Research Mind, May 2011, Pages: 692
and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies
Axis Research Mind, Nov 2011, Pages: 730
terms of CAGR among the regions considered.
On further classification, Population-Based Banks are the fastest growing segment followed by Academics andDisease-Based Banks respectively.
Report Focus
